NCT06819228 2025-10-03Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck CancerVanderbilt-Ingram Cancer CenterPhase EARLY_PHASE1 Recruiting18 enrolled